SCHEMBL21748753

SCHEMBL21748753

Cc1ccc(C(O)C[N+](=O)[O-])cn1

nearest known ligand 0.54

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.54
HPGD P15428 3/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
MAPT P10636 6/20 0.38
HSP90AA1 P07900 3/20 0.36
LMNA P02545 1/20 0.36
NTSR1 P30989 1/20 0.36
PKM P14618 1/20 0.35
MAPK1 P28482 2/20 0.35
ATM Q13315 2/20 0.35
KDM4E B2RXH2 1/20 0.35
AGTR1 P30556 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
P2RX7 Q99572 2/20 0.34
NPC1 O15118 1/20 0.34
FAAH O00519 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30783176 1.00 ALDH1A1 (0.54) ALDH1A1HPGDSMN1; SMN2MAPTHSP90AA1
SCHEMBL15797407 0.81 ALDH1A1 (0.50) ALDH1A1HPGDSMN1; SMN2MAPTHSP90AA1
SCHEMBL30353352 0.81 ALDH1A1 (0.54) ALDH1A1HPGDSMN1; SMN2MAPT
SCHEMBL25556165 0.81 ALDH1A1 (0.54) ALDH1A1HPGDSMN1; SMN2MAPT
SCHEMBL2313992 0.78 ALDH1A1 (0.51) ALDH1A1P2RX7
SCHEMBL531072 0.78 ALDH1A1 (0.68) ALDH1A1HPGDSMN1; SMN2MAPTHSP90AA1
SCHEMBL31639294 0.76 ALDH1A1 (0.49) ALDH1A1HPGDSMN1; SMN2MAPTHSP90AA1
SCHEMBL6075377 0.75 TAAR1 (0.50) HPGDMAPTLMNAMAPK1KDM4E
SCHEMBL17664582 0.75 CYP3A4 (0.40) LMNAP2RX7
SCHEMBL12352043 0.75 LMNA (0.47) MAPTLMNATDP1P2RX7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250049772-A1 PIPERIDINYL-3-(ARYLOXY)PROPANAMIDES AND PROPANOATES TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2025-02-13 US disclosed
US-12005054-B2 Piperidinyl-3-(aryloxy)propanamides and propanoates TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2024-06-11 US disclosed
CN-112236423-B Piperidinyl-3- (aryloxy) propanamides and propionic acid esters 武田药品工业株式会社 2024-02-06 CN disclosed
US-20230021834-A1 PIPERIDINYL-3-(ARYLOXY)PROPANAMIDES AND PROPANOATES TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2023-01-26 US disclosed
US-20230021834-A1 PIPERIDINYL-3-(ARYLOXY)PROPANAMIDES AND PROPANOATES TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2023-01-26 US disclosed
US-11045457-B2 Piperidinyl-3-(aryloxy)propanamides and propanoates TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2021-06-29 US disclosed
US-11045457-B2 Piperidinyl-3-(aryloxy)propanamides and propanoates TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2021-06-29 US disclosed
CN-112236423-A Piperidinyl-3- (aryloxy) propanamides and propionates 武田药品工业株式会社 2021-01-15 CN disclosed
US-20200061041-A1 PIPERIDINYL-3-(ARYLOXY)PROPANAMIDES AND PROPANOATES TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2020-02-27 US disclosed
US-20200061041-A1 PIPERIDINYL-3-(ARYLOXY)PROPANAMIDES AND PROPANOATES TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2020-02-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11045457-B2 Piperidinyl-3-(aryloxy)propanamides and propanoates SSTR4, SSTR3, NPY4R ALDH1A1 1476/4885HPGD 2783/4885SMN1; SMN2 933/4885
US-12005054-B2 Piperidinyl-3-(aryloxy)propanamides and propanoates SSTR4, SSTR3, NPY4R ALDH1A1 1476/4885HPGD 2783/4885SMN1; SMN2 933/4885
US-20250049772-A1 PIPERIDINYL-3-(ARYLOXY)PROPANAMIDES AND PROPANOATES SSTR4, SSTR3, NPY4R ALDH1A1 1476/4885HPGD 2783/4885SMN1; SMN2 933/4885
US-20200061041-A1 PIPERIDINYL-3-(ARYLOXY)PROPANAMIDES AND PROPANOATES SSTR4, SSTR3, NPY4R ALDH1A1 1476/4885HPGD 2783/4885SMN1; SMN2 933/4885
US-20230021834-A1 PIPERIDINYL-3-(ARYLOXY)PROPANAMIDES AND PROPANOATES SSTR4, SSTR3, NPY4R ALDH1A1 1476/4885HPGD 2783/4885SMN1; SMN2 933/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.